menu
    • menu

    Company profile for MaaT Pharma

    NEW Drugs in Dev: 4
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MaaT Pharma, a clinical stage company, has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating a range of cancers and Graft-versus-Host-Disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further ex...
    MaaT Pharma, a clinical stage company, has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating a range of cancers and Graft-versus-Host-Disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline, we have built a powerful discovery and analysis platform, GutPrint®, to evaluate drug candidates, determine novel disease targets and identify biomarkers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MaaT PharmaFrance Flag
    Country
    Country
    France
    Address
    Address
    317 Avenue Jean Jaurès 69007 Lyon
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.maatpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/maat-pharma/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/MaaT_Pharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MaaT Pharma Publishes Retrospective Data on GvHD in BMT Journal
    MaaT Pharma Publishes Retrospective Data on GvHD in BMT Journal

    01 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260331625825/en/MaaT-Pharma-Announces-Publication-of-Retrospective-Data-in-Third-Line-Acute-GvHD-from-the-CHRONOS-Study-in-Bone-Marrow-Transplantation-Journal

    BUSINESSWIRE
    01 Apr 2026
    Share Share
    MaaT Pharma Announces 2025 Annual Results & Business Updates
    MaaT Pharma Announces 2025 Annual Results & Business Updates

    31 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260330043869/en/MaaT-Pharma-Announces-2025-Annual-Results-and-Provides-Business-Updates

    BUSINESSWIRE
    31 Mar 2026
    Share Share
    MaaT Pharma Presents Final ARES Phase 3 Data at EBMT Meeting
    MaaT Pharma Presents Final ARES Phase 3 Data at EBMT Meeting

    23 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-23/maat-pharma-presents-the-ares-phase-3-pivotal-trial-final-data-during-the-presidential-plenary-sessi

    PHARMIWEB
    23 Mar 2026
    Share Share
    Maat Pharma To Present Four Abstracts At The 52Nd European Bone
    Maat Pharma To Present Four Abstracts At The 52Nd European Bone

    09 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260309604593/en/MaaT-Pharma-to-Present-Four-Abstracts-at-the-52nd-European-Bone-Marrow-Transplantation-Annual-Meeting-and-to-Highlight-Clinigen-Hosted-Industry-Symposium-on-acute-GvHD-Management

    BUSSINESSWIRE
    09 Mar 2026
    Share Share
    Maat Pharma Reports Monthly Voting Rights And Share Capital
    Maat Pharma Reports Monthly Voting Rights And Share Capital

    03 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-03/maat-pharma-monthly-information-regarding-the-total-number-of-voting-rights-and-shares-comprising-t

    PHARMIWEB
    03 Feb 2026
    Share Share
    Maat Pharma Initiates IMMUNOLIFE Phase 2 Study On Gut Microbiome
    Maat Pharma Initiates IMMUNOLIFE Phase 2 Study On Gut Microbiome

    20 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260120896543/en/MaaT-Pharma-Announces-First-Patient-Randomized-in-IMMUNOLIFE-Phase-2-Study-Sponsored-by-Gustave-Roussy-To-Explore-the-Role-of-the-Gut-Microbiome-To-Overcome-ICI-Resistance-in-Advanced-NSCLC-Patients-with-Antibiotic-Induced-Dysbiosis

    BUSINESSWIRE
    20 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search